Poor outcomes associated with +der(22)t(9;22) and -9/9p in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia receiving chemotherapy plus a tyrosine kinase inhibito

In patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) treated with chemotherapy plus a tyrosine kinase inhibitor (TKI), the prognostic impact of additional chromosomal abnormalities (ACAs) is not well-established. We evaluated the prognostic impact of individual...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Hematol
Main Authors: Short, Nicholas J., Kantarjian, Hagop M., Sasaki, Koji, Ravandi, Farhad, Ko, Heidi, Yin, C. Cameron, Garcia-Manero, Guillermo, Cortes, Jorge E., Garris, Rebecca, O'Brien, Susan M., Patel, Keyur, Khouri, Maria, Thomas, Deborah, Jain, Nitin, Kadia, Tapan M., Daver, Naval, Benton, Christopher B., Issa, Ghayas C., Konopleva, Marina, Jabbour, Elias
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5495018/
https://ncbi.nlm.nih.gov/pubmed/28006851
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.24625
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados